Introduction {#Sec1}
============

Renal tubular cells have unique fluid and electrolyte transport capabilities across the distinct apical and basolateral membrane domains. Tight junctions maintain the functional integrity and polarity of tubular surface membrane, and regulate paracellular and transcellular transports (Fish and Molitoris [@CR8]; Lee et al. [@CR23]; Weinstein [@CR39]). The tight junction complex consists of multiple adhesion proteins linking it to the cytoskeleton of the individual cells.

Occludin, ZO-1, and the claudin family are major components of the growing number of tight junction proteins (Furuse et al. [@CR9]; Mitic et al. [@CR28]; Schneeberger and Lynch [@CR33]; Stevenson et al. [@CR34]). Occludin carries out an adhesive function when interacting with ZO-1 in kidney cells (Furuse et al. [@CR10]; Van Itallie and Anderson [@CR35]). Although the exact roles of occludin and ZO-1 in the kidney are not completely understood, their distribution varies markedly along the tubule segments. The amount of occludin and ZO-1 expression is significantly greater in more distal tubular segments than in proximal tubules, which correlates with the greater transepithelial electrical resistance in those segments (Gonzalez-Mariscal et al. [@CR11]). In cultured cells, overexpression of occludin dramatically increases transepithelial resistance (Balda et al. [@CR2]; McCarthy et al. [@CR27]). Thus, occludin and ZO-1 may play an important role in increasing the adhesive strength of the tight junction in renal tubular epithelia.

Renal ischemic injury is a commonly observed complication in hospitalized patients that results in multiple impairments of water and ion transport (Clarkson et al. [@CR5]). The disruption of tight junctions is an important component of the pathogenesis of renal ischemic injury and causes polarity alteration of tubular epithelium (Fish and Molitoris [@CR8]; Lee et al. [@CR23]; Molitoris et al. [@CR29], [@CR30]). Distorted distributions of the tight junction proteins occludin and ZO-1 have been observed with ATP depletion (an in vitro model of renal ischemia) in cultured cells (Bacallao et al. [@CR1]; Gopalakrishnan et al. [@CR12]). ZO-1 staining in renal allograft recipients with sustained acute renal failure exhibits diminished intensity and redistribution in the proximal tubule (Kwon et al. [@CR21]). Ischemic injury also has been shown to induce glomerular podocyte effacement in association with ZO-1 dissociation (Wagner et al. [@CR36]). However, the effects of ischemic injury on occludin and ZO-1 distribution in renal epithelial cells have not yet been fully investigated in the kidney.

In the present study, we show that renal ischemia--reperfusion injury causes cellular damages not only in the proximal tubule but also in the collecting duct and that the disruption of tight junctions is cell-specific to intercalated cells in the collecting duct. The collecting duct is composed of two histologically different cell types, the principal cells and intercalated cells. The principal cells reabsorb water, whereas the intercalated cells are involved in acid--base homeostasis (Madsen and Tisher [@CR26]). Renal ammonia excretion is a central component of net acid excretion and ischemia--reperfusion injury decreases renal ammonia excretion (Han et al. [@CR16]; Wagner et al. [@CR37]; Weiner and Verlander [@CR38]). We show that disruption of tight junctions is associated with the polarity loss or delocalization of the ammonia transporting Rhesus protein, Rhcg, as well as other acid--base transporter proteins in intercalated cells. The results may have significant value in understanding clinical manifestations of renal ischemic injury such as metabolic acidosis.

Materials and methods {#Sec2}
=====================

Animals and surgical procedures {#Sec3}
-------------------------------

Male Sprague--Dawley rats weighing 200--250 g were used in all experiments. Animals were maintained in a temperature-controlled room with alternating 12:12-h light--dark cycles and had free access to water and food throughout the experiment. These studies were approved by the Ewha Womans University Institutional Animal Care and Use Committee (EMRI 07-0073, 08-0083).

Animals were anesthetized with an intraperitoneal injection of tiletamine/zolazepam (10 mg/kg; Zoletil 50, Virbac Laboratories, Carros, France) and 2% xylazine hydrochloride (2 mg/kg; Rumpun, Bayer Korea, Ansan, Korea). After the abdomen was opened through a midline incision, both renal pedicles were exposed and cleaned by blunt dissection. Microvascular clamps (RS-5422, Roboz Surgical Instrument Co., Inc., Gaithersburg, MD, USA) were placed on both renal arteries to completely block renal blood flow. After 30 min, the clamps were removed and blood flow returned to the kidneys. Control animals underwent sham operation. The animals were killed 6 h after reperfusion. Arterial blood samples of the animals were collected from the abdominal aorta. The collected blood sample was placed on ice, and the blood gas was immediately measured (Beckman Instruments, Palo Alto, CA, USA).

Tissue preservation {#Sec4}
-------------------

The kidneys were first perfused briefly through the abdominal aorta with cold PBS and subsequently perfused with the fixative solution, periodate-lysine-2% paraformaldehyde (PLP), for 10 min. The kidneys were cut transversely into 1- to 2-mm thick slices and immersed in PLP overnight at 4°C. The tissue was rinsed in PBS, dehydrated in a series of ethanol, and embedded in wax (Polysciences, Inc., Warrington, PA, USA) for light microscopy.

Antibodies {#Sec5}
----------

Mouse anti-occludin monoclonal antibodies (Zymed Laboratories, San Francisco, CA, USA; catalog No 33-1500) and rabbit anti-ZO-1 polyclonal antibodies (Zymed Laboratories, San Francisco, CA, USA; catalog No 40-2300) were used. Aquaporin 1 (Chemicon Inc., Temecula, CA, USA; catalog No AB3065), bumetanide-sensitive Na^+^/K^+^/2Cl^−^ cotransporter (NKCC2; Jeon et al. [@CR19]), aquaporin 2 (Chemicon Inc., Temecula, CA, USA; catalog No AB3066), Rh C glycoprotein (Rhcg; Han et al. [@CR16]), and anion exchanger 1 (AE1; Alpha Diagnostics, San Antonio, TX, USA; catalog No AE11-A) were used to identify the proximal tubule and descending thin limb, thick ascending limb, collecting duct principal cells, collecting duct intercalated cells, and type A intercalated cells, respectively.

Light microscopic immunohistochemistry {#Sec6}
--------------------------------------

Four micrometer-thick wax sections were processed for immunohistochemistry using immunoperoxidase procedures, as described previously (Han et al. [@CR13], [@CR14], [@CR15]). The sections were dewaxed with xylene and ethanol and rinsed in PBS. Endogenous peroxidase activity was blocked by incubating the sections in 3% H~2~O~2~ for 30 min. The sections were treated with proteinase K (DakoCytomation, Carpinteria, CA, USA) for 10 min and blocked with the blocking solution (DakoCytomation, Carpinteria, CA, USA) for 30 min before incubation with primary antibody (occludin 1:200; aquaporin 1:1000; NKCC2 1:500) overnight at 4°C. The sections were washed in PBS and incubated for 1 h with peroxidase-conjugated secondary antibodies against mouse or rabbit IgG (Jackson ImmunoResearch laboratories, West Grove, PA, USA) diluted 1:100 in PBS. The sections were again washed with PBS and then exposed to a mixture of 0.05% 3,3′-diaminobenzidine and 0.01% H~2~O~2~. The sections were washed in Tris--HCl buffer, dehydrated with graded ethanol and xylene, mounted, and observed by light microscopy.

Double immunohistochemistry {#Sec7}
---------------------------

Colocalization was accomplished using sequential immunoperoxidase procedures, as described previously (Han et al. [@CR16]). Briefly, the first immunoperoxidase procedure used the protocol for single labeling described above. After the diaminobenzidine reaction, the sections were washed in PBS and incubated in 3% H~2~O~2~ for 30 min and blocked with the blocking solution. The sections were treated for 1 h with the second primary antibodies (aquaporin 1 1:1000; NKCC2 1:500; Rhcg 1:1000), washed in PBS, incubated with the secondary antibodies, and then washed with PBS. Vector SG (Vector Laboratories, Burlingame, CA, USA) was used as the chromogen to produce a blue label easily distinguishable from the brown label produced by the diaminobenzidine used for detection of the first protein. The sections were washed in Tris--HCl buffer, dehydrated with graded ethanol and xylene, mounted, and observed by light microscopy.

Confocal microscopy {#Sec8}
-------------------

Kidney sections were dewaxed and rehydrated in a graded series of ethanol. The sections were treated with proteinase K (DakoCytomation, Carpinteria, CA, USA) for 10 min and blocked with the blocking solution (DakoCytomation, Carpinteria, CA, USA) for 30 min before incubation with a mixture of primary antibodies (occludin 1:100; AE1 1:100) overnight at 4°C. The sections were washed in PBS and incubated for 1 h with a mixture of Cy3-conjugated donkey anti-mouse IgG and FITC-conjugated donkey anti-rabbit IgG (Jackson ImmunoResearch laboratories, West Grove, PA) diluted 1:100 in PBS, respectively. Coverslips were mounted with VectaShield mounting media. Images were captured on a Zeiss LSM5 PASCAL.

Immunoblot analysis {#Sec9}
-------------------

Kidneys were divided into the cortex and medulla and processed for immunoblot analysis, as described previously (Han et al. [@CR15]). Tissues were homogenized in lysis buffer containing 20 mM Tris--HCI, 1% Triton X-100, 150 mM sodium chloride, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate, 0.02% sodium azide, 1 mM EDTA, 10 μM leupeptin, and 1 mM phenylmethylsulfonyl fluoride. The homogenate was centrifuged at 3,000*g* for 20 min at 4°C. After determination of protein concentration in the supernatant by the Coomassie method (Pierce, Rockford, IL, USA), samples were loaded (20 μg/lane) and underwent electrophoresis on sodium dodecyl sulfate-polyacrylamide gels under reducing conditions. Proteins were transferred to nitrocellulose membranes by electroblotting. To reduce nonspecific antibody binding, the membranes were blocked with 5% nonfat dried milk for 30 min at room temperature, and then incubated for 24 h at 4°C with anti-occludin antibody (1:1,000). After three washes, the blot was incubated with a peroxidase conjugated donkey anti-mouse IgG (1:1,000) for 2 h at room temperature. Samples were visualized using an enhanced chemiluminescence system (Amersham Life Science, Buckinghamshire, UK) after a 5- to 30-min exposure at room temperature. Densitometric analysis was performed using the Zero-Dscan software of the Eagle EYETMII Still Video System (Stratagene, La Jolla, CA, USA).

Statistics {#Sec10}
----------

Results are presented as mean ± SD. Statistical analyses were performed using Student's unpaired *t* test, and *P* \< 0.05 was taken as statistical significance.

Results {#Sec11}
=======

Physiological parameters {#Sec12}
------------------------

The results of the arterial blood gas are summarized in Table [1](#Tab1){ref-type="table"}. Renal ischemia--reperfusion injury decreased significantly blood bicarbonate level compared with control animals (20.6 ± 2.36 vs*.* 25.1 ± 2.02 mmol/L). Arterial carbon dioxide tension (PaCO~2~) was slightly reduced indicating a respiratory compensation in ischemic rats. There were no significant differences in serum sodium, potassium, and chloride concentrations.Table 1Effects of ischemia--reperfusion injury on blood pH and electrolyte concentrationControlIRpH7.38 ± 0.047.37 ± 0.05HCO~3~^−^ (mmol/L)25.1 ± 2.020.6 ± 2.4\*pCO~2~ (mmHg)44.1 ± 7.137.1 ± 6.3Plasma Na^+^ (mmol/L)131 ± 3.0132 ± 2.1Plasma K^+^ (mmol/L)4.6 ± 0.65.1 ± 0.4Plasma Cl^−^ (mmol/L)108 ± 2111 ± 1Values are mean ± SD of five rats (\**P* \< 0.05)

Localization of occludin and ZO-1 in the normal rat kidney {#Sec13}
----------------------------------------------------------

Occludin was expressed from the cortex to the tip of the inner medulla. In both normal and sham-operated control kidneys, strong occludin immunoreactivity was observed in the distal nephron segments, including the thick ascending limb, distal convoluted tubule, and collecting duct. High-magnification microscopic examination demonstrated a classic dot or thread-like expression pattern at the apical end of the lateral membrane in the tubular epithelial cells, as expected for the location of the tight junction (Fig. [1](#Fig1){ref-type="fig"}a, b). Occludin immunolabeling was not detected in the glomerulus, proximal tubule, and blood vessels in the rat kidney (Fig. [1](#Fig1){ref-type="fig"}a, b). The thin limbs of the loop of Henle showed moderate occludin immunoreactivity. To identify the descending thin limb, we used aquaporin 1 as a marker. Occasionally, the transition point from the descending thin limb to the ascending thin limb was observed in the inner medulla, and occludin was expressed in both thin limbs (Fig. [1](#Fig1){ref-type="fig"}f--h).Fig. 1Occludin and ZO-1 expression in control kidney. Representative of occludin (**a**, **b**), ZO-1(**c**--**e**), and occludin-AQP1 confocal (**f**--**h**) immunostaining images obtained from sham-operated control kidneys. Occludin (*brown*) immunoreactivity was observed as dot-and-line patterns at the apical end of the lateral membrane in tubular epithelial cells in the cortex (**a**) and outer medulla (**b**). Occludin was expressed primarily in the distal tubule (*DT*) including the thick ascending limb (*TAL*). No occludin immunolabel was detected in glomeruli (*G*), proximal tubule (*PT*), or blood vessels, including the vascular bundles (*VB*). ZO-1 (*brown*) immunoreactivity was observed in all tubular segments, including the proximal tubule (*PT*) and distal tubule (*DT*) (**c**--**e**). ZO-1 labeling also appeared in the glomerular parietal epithelial cells (*arrows*) and in endothelial cells (*arrowheads*) of all blood vessels including the glomerular capillary, peritubular capillary, arcuate artery (*AA*), and vascular bundle (*VB*). To identify the thin limbs of the loop of Henle, confocal immunofluorescence staining for occludin (*red*) and AQP1 (*green*) were performed (**f**--**h**). Occasionally, transition points (*white arrows*) from the AQP1-positive descending thin limb (*DTL*) to AQP1-negative ascending thin limb (*ATL*) were observed and occludin immunoreactivity appeared in both thin DTL and ATL segments (**g**, **h**). Results are representative of findings in the five control rat kidneys

ZO-1 immunoreactivity was strong in the thick ascending limb, distal convoluted tubules, and collecting duct and was moderate in thin limbs of the loop of Henle in the normal kidney (Fig. [1](#Fig1){ref-type="fig"}c--e). In contrast to occludin, ZO-1 expression was also observed in the parietal epithelium of Bowman's capsule and in vascular endothelial cells, including the arcuate artery, interlobular artery, glomerular capillaries, peritubular capillaries, and vascular bundles (Fig. [1](#Fig1){ref-type="fig"}c--e). Also in contrast to occludin, ZO-1 immunolabel was observed in the proximal tubule, although the intensity of immunolabel was less than that observed in distal nephron segments (Fig. [1](#Fig1){ref-type="fig"}c).

Abnormal localization of occludin and ZO-1 after renal ischemia--reperfusion injury {#Sec14}
-----------------------------------------------------------------------------------

After ischemia--reperfusion injury, abnormal localization of occludin was observed in the outer medulla region (Fig. [2](#Fig2){ref-type="fig"}). Typical dot or thread-like patterns of occludin immunoreactivity was disrupted. Instead, occludin was distributed diffusely in the cytoplasm in a subset of tubular epithelial cells in the outer medulla of IR injury kidneys (Fig. [2](#Fig2){ref-type="fig"}d).Fig. 2Effects of IR injury on occludin immunolabel in the rat kidney. Representative micrographs showing occludin (**a**, **d**), AQP1 (**b**, **e**) and occludin-AQP1 double immunostaining (**c**, **f**) images in the outer medulla in sham-operated control (**a**--**c**, *n* = 5) and IR (**d**--**f**, *n* = 5) kidneys. *Dashed lines* indicate boundary between the outer stripe of the outer medulla (*OSOM*) and inner stripe of the outer medulla (*ISOM*). Compared with control kidneys, abnormal localization of occludin (*brown*) immunoreactivity was observed in the outer medullary region in ischemic kidneys (**d**). In a subpopulation of cells, occludin diffusely localized in the cytoplasm (inset, *arrowheads*) in the ischemic kidneys (**d**). Many AQP1 (*brown* in **b**, **e**; *blue* in **c**, **f**)-positive proximal tubular (*PT*) cells lost polarity, detached from basement membrane, and were present in the tubule lumen (*arrows*) in ischemic kidneys (**e**, **f**). Occludin (*brown* in **c**, **f**) immunoreactivity was not observed in the proximal tubule either under control or following IR injury

Because there are three different tubular segments (the proximal straight tubule, thick ascending limb, and collecting duct) in the outer medulla, we used specific marker proteins to identify the different epithelial segments and cells affected by IR injury. We used AQP1 to identify proximal tubule segments, NKCC-2 to identify the thick ascending limb of the loop of Henle and Rhcg, and AQP2 and AE1 to identify collecting duct segments.

Many aquaporin 1-positive proximal tubule cells were damaged and detached into the tubular lumen in IR kidneys (Fig. [2](#Fig2){ref-type="fig"}e). However, occludin immunoreactivity was not detected in the proximal tubule cells in either control or ischemic kidneys (Fig. [2](#Fig2){ref-type="fig"}c, f).

NKCC2-positive thick ascending limb cells were relatively intact and did not show detectable morphological damage in this model of ischemia--reperfusion injury (Fig. [3](#Fig3){ref-type="fig"}). Occludin expression was strong in the thick ascending limb in both control and IR kidney, and there was no change in occludin distribution in the thick ascending limb in response to IR injury (Fig. [3](#Fig3){ref-type="fig"}b, d).Fig. 3Effects of IR injury on TAL segments. Representative images of NKCC2 (**a**, **c**) and occludin-NKCC2 double immunostaining (**b**, **d**) in the outer medulla of sham-operated control (**a**, **b**, *n* = 5) and IR (**c**, **d**, *n* = 5) kidneys. Apical NKCC2 (*brown* in **a**, **c**; *blue* in **b**, **d**) immunoreactivity was used to identify the thick ascending limb (*TAL*). No detectable morphological damages were observed in the TAL, although many neighboring tubular cells (*arrows*) were severely damaged after IR injury. Therefore, there were no changes in occludin (*brown* in **b**, **d**) localization in the TAL after IR injury

Ischemia--reperfusion injury caused considerable damage to a subset of cells in the outer medullary collecting duct (OMCD). To determine whether the damage is specific to either intercalated cells or principal cells, the two primary cell types present in the collecting duct, we double-immunolabel with Rhcg, to identify intercalated cells, and AQP2, to identify principal cells. We observed that Rhcg-positive intercalated cells were detached frequently from the basement membrane, whereas principal cells, in contrast, appeared intact and undamaged (Fig. [4](#Fig4){ref-type="fig"}a, f). To identify whether disturbances in occludin localization were present and whether changes in its localization were specific to intercalated cells, we performed double-immunolabel fluorescent microscopy using antibodies to occludin and the intercalated cell marker, AE1. Confocal fluorescent microscopy confirmed that occludin disruption in the OMCD was specific to damaged intercalated cells and that occludin lost its typical apical tight junction localization and was localized diffusely in detached intercalated cells. Occludin expression was only slightly delocalized in cells remaining in the OMCD (Fig. [4](#Fig4){ref-type="fig"}b--e, g--j).Fig. 4Effects of IR injury in the OMCD. Representative of AQP2-Rhcg double immunohistochemistry (**a**, **f**) and occludin-AE1 confocal fluorescent microscopy (**b**--**e**, **g**--**j**) images in the outer medulla in sham-operated control (**a**--**e**, *n* = 5) and IR (**f**--**j**, *n* = 5) kidneys. Compared with control, many Rhcg (*blue*)-positive collecting duct (*CD*) cells detached from the basement membrane and were present in the tubule lumen (*arrows*) in ischemic kidneys (**f**). However, AQP2 (*brown*)-positive cells were not damaged after IR injury. Confocal images confirmed the intercalated cell-specific damage in the CD. In control kidneys, occludin (*red*) labeling was observed at the apical end of the lateral membrane in both principal and intercalated cells (**e**, *white arrows*). In IR injury kidneys, both occludin and AE1 (*green*) lost their normal polarity and were localized diffusely in the cytoplasm in cells released into the lumen (**j**, *white arrow*). Partial delocalization or internalization of occludin and AE1 was also observed in cells still remaining in the tubule wall (*white arrowheads*, inset) in ischemic kidneys (**j**)

IR injury also resulted in significant changes in ZO-1 immunolabel in the outer medulla. However, in contrast to occludin, ZO-1 distribution was disrupted in both the proximal tubule and the collecting duct, but not in the thick ascending limb of the loop of Henle (Fig. [5](#Fig5){ref-type="fig"}). In both the proximal tubule and the OMCD, ZO-1 immunolabel intensity was decreased in the tight junction regions and its localization was often diffuse in damaged cells, rather than being limited to the tight junction regions (Fig. [5](#Fig5){ref-type="fig"}c, d).Fig. 5Effects of IR injury on ZO-1 expression in the outer medulla. Representative micrographs of ZO-1 localization in the outer medulla in control (*n* = 5) and IR (*n* = 5) kidneys. In control kidneys (**a**, **b**), ZO-1 (*brown*), immunoreactivity was observed in the proximal tubule (*PT*) as well as in the collecting duct (*CD*). In ischemic kidneys (**c**, **d**), ZO-1 localization was distorted and abnormally localized in the cytoplasm (*arrowheads*, inset). Occasionally, a combination of both delocalization and upregulation of ZO-1 expression was observed in some cells (*arrows*) in the PT and CD

Western blot analysis {#Sec15}
---------------------

Occludin bands were detected at \~60 kDa. There was no significant change in occludin protein expression after ischemia--reperfusion injury in the cortex (not shown) and medulla (Fig. [6](#Fig6){ref-type="fig"}).Fig. 6Effects of IR injury on occludin protein expression. Total occludin protein expression in the medulla of control (*C1*-3) and ischemic kidneys (*IR1*-3) was quantified using immunoblot analysis. There was no significant difference between the two groups

Discussion {#Sec16}
==========

The present study provides important new information regarding both the distribution of the tight junction proteins, occludin and ZO-1, and the effect of IR injury on their localization. In the rat kidney, occludin is localized mainly in distal nephron segments, whereas ZO-1 is widely expressed both in epithelial and endothelial cells. IR injury causes cell-specific changes in occludin localization, with development of diffuse intracellular localization in collecting duct intercalated cells, but not principal cells, and no detectable change in the thick ascending limb. ZO-1 localization was altered in both proximal tubule and collecting duct cells, but not in the thick ascending limb. Thus, the distribution of occludin differs from that of ZO-1, and ischemia--reperfusion injury causes cell-specific disruption of tight junction proteins in the collecting duct.

The current study provides the first examination of occludin expression in the rat kidney. In particular, the distinct axial expression pattern, collecting duct and distal tubule \> loop of Henle \>\> proximal tubule, parallels both transepithelial resistance and the complexity of junctional intramembrane strands (Claude and Goodenough [@CR6]). Axial variations in occludin expression also parallel axial variations in the expression of other tight junction proteins, specifically claudins, which exhibit differences in specific claudin family member expression in different epithelial segments (Kiuchi-Saishin et al. [@CR20]).

Occludin localization may differ, but only slightly, between the rat, rabbit, and mouse kidney. In the rabbit kidney, the highest level of occludin expression is in the distal nephron segments similar to that observed in the current study in the rat kidney (Gonzalez-Mariscal et al. [@CR11]). Proximal tubule cells in the rabbit kidney also express low level occludin expression, less than 1% of its expression in the collecting duct (recalculation of data from Gonzalez-Mariscal et al. [@CR11]), which contrasts with the findings in the rat kidney (current study), where occludin was not detected in the rat proximal tubule despite the use of multiple technical approaches. Thus, in the rat kidney, occludin is either not expressed in the proximal tubule or expressed at very low levels. In the mouse kidney, occludin immunolabel appears to colocalize with claudin-8, suggesting collecting duct and distal tubule expression, and with claudin-2 in the thin descending limb of the loop of Henle (Kiuchi-Saishin et al. [@CR20]). Whether occludin immunolabel was present in the mouse thick ascending limb of the loop of Henle, as observed in the rat kidney in the current study, was not reported (Kiuchi-Saishin et al. [@CR20]). Thus, in the rat, rabbit, and mouse kidney, occludin immunolabel expression appears to exhibit substantial axial heterogeneity, paralleling axial variations in transepithelial resistance, with substantially less proximal tubule expression than collecting duct expression.

Although occludin is a critical component of the tight junction and thus likely to play a central role in paracellular permeability and transepithelial resistance and in epithelial cell polarity biogenesis, its specific role cannot be determined definitively at present. Expression of occludin mutants lacking the C-terminal cytoplasmic domain, which binds to the submembrane cytoskeleton, alters size-selective paracellular permeability, disrupts apical junctional ring formation, and prevents normal localization of proteins to specific apical and basolateral plasma membrane domains (Balda et al. [@CR2]). In contrast, occludin-deficient ES cells are able to generate apparently normal cystic embryoid bodies, normal appearing tight junction strands, and normal concentration of ZO-1 at tight junctions (Saitou et al. [@CR31]). Occludin-deficient mice exhibit a number of abnormalities, including chronic inflammation and hyperplasia of the gastric epithelium, calcification in the brain, testicular atrophy, loss of cytoplasmic granules in striated duct cells of the salivary gland, and thinning of the compact bone (Saitou et al. [@CR32]). In occludin-deficient mice, renal epithelial cell tight junctions were normal by immunofluorescence microscopy and electron microscopy, but whether there were differences in fluid and electrolyte homeostasis or in epithelial polarity have not been reported (Saitou et al. [@CR32]). These observations suggest that although occludin has an important role in paracellular permeability and epithelial polarity, in its absence adaptive changes in other proteins, possibly by claudin family members that coexist in tight junctions, can substitute for occludin.

ZO-1, another member of the tight junction protein complex, exhibited a different epithelial cell distribution than observed for occludin, suggesting a different functional role. ZO-1 was present in all renal epithelial cells. In contrast to occludin, an integral membrane protein, ZO-1 is a membrane-associated protein that appears to function as a scaffolding protein for many tight junction proteins. In addition to interacting with occludin, ZO-1 also interacts with multiple claudin family members, ZO-2, ZO-3, the ZO-1-associated nucleic acid-binding proteins (ZONAB), the coxsackievirus and adenovirus receptor (CAR), and myosin and actin filaments. Current models suggest that ZO-1 functions primarily as a scaffolding protein involved in tight junction biogenesis, providing a link to the actin cytoskeleton, and transducing regulatory signals, both to and from the tight junction proteins, occludin and claudins (Fanning and Anderson [@CR7]; Landau [@CR22]).

Renal ischemia--reperfusion causes cellular and morphologic damage primarily in cells in the outer medullary region (Heyman et al. [@CR17], [@CR18]; Lieberthal and Nigam [@CR25]). Presumably, this is due to altered tissue oxygenation in this region, making it more susceptible to ischemia--reperfusion injury. There are three different tubular segments in the outer medulla: the proximal tubule (S3 segment), the thick ascending limb, and the collecting duct. Although the proximal tubule is an important locus of ischemia--reperfusion injury in the IR injury experimental model, the current study adds to accumulating evidence that the collecting duct, in general, and OMCD intercalated cells, in particular, are also susceptible to ischemia--reperfusion injury (Han et al. [@CR16]; Heyman et al. [@CR18]). The current study adds to these previous studies, both by confirming intercalated cell-specific cellular damage in response to IR injury and by showing that the tight junction proteins, occludin and ZO-1, undergo specific alterations in their cellular localization, with removal from tight junction sites and instead diffuse cellular localization.

Ischemia--reperfusion injury leads to altered glomerular filtration and solute excretion because of cellular extrusion from the basement membrane, leading to intra-tubular obstruction and increased intraluminal pressures, filtrate backleak, and altered epithelial cell ion transport. At least in part this involves altered structure and function of the slit diaphragm proteins, neph1 and ZO-1, as well as the tubular adherens junctional complex proteins, E-cadherin and catenin (Bush et al. [@CR3]; Wagner et al. [@CR36]). The current study adds to this information by showing that IR injury also alters expression of the tight junction proteins, occludin and ZO-1, in specific renal tubular cells. Ischemia--reperfusion caused abnormal ZO-1 distribution in both the proximal tubule and collecting duct, indicating tight junction disruptions in both segments and alterations in occludin expression in OMCD intercalated cells.

Occludin may play a critical role in the pathogenesis of collecting duct injury during renal ischemia--reperfusion insults. Occludin expression in the collecting duct was very strong and abnormally distributed after ischemia--reperfusion, and these changes were limited to intercalated cells, one of the two morphologically and functionally different cell types present in the collecting duct. These differential effects on intercalated cell, but not principal cell, and occludin expression parallel differential sensitivity of these two cell types to injury. Recently, we reported that renal ischemia--reperfusion injury caused intercalated cell-specific cell detachment and apoptosis (Han et al. [@CR16]). Butt et al. demonstrated that intercalated cells preferentially lose polarity during fetal urinary tract obstruction (Butt et al. [@CR4]). Thus, abnormal localization of occludin observed in intercalated cells after ischemia--reperfusion injury may contribute to intercalated cell-specific injury.

The cell-specific change of occludin distribution in the collecting duct may be important to fluid and electrolyte derangements that result from renal ischemia--reperfusion injury. Renal ischemic injury frequently induces metabolic acidosis and impairs ammonia excretion (Clarkson et al. [@CR5]; Han et al. [@CR16]; Lenhart et al. [@CR24]). We demonstrated recently that renal ischemia--reperfusion injury decreased urinary ammonia excretion and induced loss of epithelial polarity of multiple proteins involved in renal ammonia secretion, including the ammonia transporter family members, Rh B and Rh C glycoprotein, the vacuolar H^+^-pump, H^+^-ATPase, and the basolateral anion exchange AE1 (Han et al. [@CR16]). The current study also showed that renal ischemia--reperfusion significantly decreased blood bicarbonate concentration (Table [1](#Tab1){ref-type="table"}). Because renal ammonia excretion requires generation of steep transepithelial ammonia and pH gradients across the collecting duct, intact tight junction function is necessary. Disruption of tight junctions may enable a backleak of H^+^, ammonia, and bicarbonate, thereby impairing net acid excretion and contributing to development of metabolic acidosis (Fig. [7](#Fig7){ref-type="fig"}). In the present study, abnormal localization of occludin was closely related to the polarity loss or partial internalization of intercalated cell-specific transporters in the collecting duct, which we demonstrated recently in response to IR injury (Han et al. [@CR16]). Intercalated cells play an important role in acid--base homeostasis and the ischemia-induced disruption of tight junction proteins may contribute to the development of collecting duct dysfunction.Fig. 7Effects of renal ischemia--reperfusion injury on occludin and acid--base transporter proteins. Intercalated cell-specific delocalization of occludin may cause the polarity loss or partial internalization of H^+^-ATPase, Rhcg, and AE1. Abnormal occludin distribution may also lead to backleak (*curved arrows*) of secreted ions through the paracellular pathways

In summary, the current studies demonstrate the expression of occludin and ZO-1 in the normal rat kidney and in response to ischemia--reperfusion injury. ZO-1 is widely expressed in renal epithelial and endothelial cells, consistent with ZO-1 mediating a central role as a membrane-associated protein involved in scaffolding functions in cell--cell interaction. Occludin expression is localized to distal epithelial segments. Ischemia--reperfusion injury induces specific changes in occludin expression in collecting duct intercalated cells, which parallels damage to intercalated cell polarity and integrity, and likely contributes to the altered acid--base homeostasis which occurs.
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